Allied Corp. announced that following an extensive regulatory review, it has received ANVISA approval for Brazilian importation. On April 27th, 2022 Allied announced the signing of a forward purchase agreement for the manufacturing and sell-through of medical products destined for Brazil.

On June 09, 2022 Allied further announced the successful initial shipment for this forward purchase agreement. By way of this announcement, Allied has now obtained ANVISA approval for these transactions. The Brazilian Health Regulatory Agency (ANVISA) controls the importation of medical products to the Brazilian market.

ANVISA's role is to promote the protection of the population's health by executing sanitary control of the production, marketing and use of products and services subject to health regulation, including related environments, processes, ingredients and technologies, as well as the control of ports, airports and borders. Allied has now met the required regulatory requirements for Brazilian ANVISA and is now importing into the Brazilian medical market.